Patient convenience and our cloud-based platform enable clinical trial sponsors to achieve better results at lower cost.
Transparency Life Sciences is the first all-digital drug development services company. Our crowdsourcing software and mobile health technology enable drug candidates to advance through clinical trials with unprecedented patient convenience, data relevance, efficiency and affordability.
Our platform is an all-digital solution that facilitates development of new drugs with more informative data and optimized labels, and produces successful clinical trials with faster timelines and smaller budgets.
Our online, crowdsourced approach to clinical protocol design helps craft study protocols co-designed by patients and physicians that are relevant to real-world medical needs
Learn More
Our virtual trial hub integrates telemedicine, mobile health and cloud technology to run trials that are simpler for everyone and result in faster, more cost-effective delivery
Learn More
Our approach to personalized patient digital phenotyping, ‘digityping’ for short, uses mobile health technology to identify and stratify the right participants for each clinical trial
Learn More
Our platform is an all-digital solution that facilitates development of new drugs with more informative data and optimized labels, and produces successful clinical trials with faster timelines and smaller budgets.
Our online, crowdsourced approach to clinical protocol design helps craft study protocols co-designed by patients and physicians that are relevant to real-world medical needs
Learn More
Our virtual trial hub integrates telemedicine, mobile health and cloud technology to run trials that are simpler for everyone and result in faster, more cost-effective delivery
Learn More
Our approach to personalized patient digital phenotyping, ‘digityping’ for short, uses mobile health technology to identify and stratify the right participants for each clinical trial
Learn More
“We applaud Transparency Life Sciences for being a valued partner of our Foundation, and for creating a model in which patients are more than subjects, but thoughtful collaborators in clinical trial design and execution.”
– Ginger Spitzer, Executive Director, Foundation for Sarcoidosis Research
“Transparency Life Sciences’ crowdsourcing expertise obtained fresh insights for our protocol assessing metformin in prostate cancer. Their commitment to all-digital clinical trials will benefit patients and investigators, and help achieve more efficient and more informative clinical trials.”
– Dr. Matthew Galsky, Professor of Hematology-Oncology, Mt. Sinai School of Medicine
“Transparency Life Sciences pioneered open sourcing design of clinical trial protocols and was one of the first to execute ‘virtual’ studies; implementation of their model will enable true patient centric clinical research.”
– Jeffrey Kasher, President, Patients Can’t Wait, LLC; former VP and COO, Global Clinical Development Organization, Eli Lilly and Company
Browse below to find a Protocol Builder to participate in, or to see if a study you’re interested in is enrolling patients. Check back often since new projects will be added frequently.
View all projects
Always stay in the loop.
Sign up for our newsletter for the latest project updates.
